Abstract
Purpose
This study aimed to identify and describe the outcomes of different endoscopic treatments and the predictive factors affecting success in the treatment of symptomatic vesicoureteral reflux (VUR) after kidney transplantation.
Methods
Patients who had undergone endoscopic injection treatment for symptomatic VUR detected by VCUG with at least 1-year follow-up were included in the study. Patients with dysfunctional and/or obstructive voiding patterns were excluded from the study. We retrospectively evaluated the patient’s characteristics, operative information about the type of injection (one, two, or four-point) and the bulking agent (DX-HA, PPC), and perioperative data. Clinical success was defined as no febrile UTI, and radiological success was defined as the absence of VUR in VCUG 3 months after the operation. Clinical success, radiological success, and encountered complications were statistically analyzed.
Results
A total of 76 patients were included in this study. The one-point, two-point, and four-point injection technique was applied to 32 (42.1%), 13 (17.1%), and 31 (40.7%) of patients, respectively. PPC and DX-HA were used as bulking agents in 54 (71.1%) and 22 (28.9%) patients, respectively. The clinical success rate was 73.7% (n = 56). In logistic regression analysis, a significant efficacy of the four-point technique was observed in the univariate analysis of clinical success (p = 0.042). The radiological success rate was 40.8% (n = 31). In the logistic regression analysis, DX-HA and PPC radiological success was attained in 4 (18.1%) and 27 (50%) patients, respectively (p = 0.01). Ureterovesical junction (UV) stricture developed in 5 (6.5%) patients. There was no difference between injection techniques and bulking agents in terms of the development of UV stricture (p = 0.32; p = 0.08).
Conclusion
The success of endoscopic treatment in patients with VUR after kidney transplantation can be increased by multiple injections. Furthermore, PPC can be used to obtain a higher radiological success.
Similar content being viewed by others
References
Molina G, Feitosa LC, Martin X, LeFrancois N, Desmettre O, Cloix P, Boillot O, Dawahra M, Pouteil-Noble C, Brunet M et al (1994) Incidence of vesico-ureteral reflux after allograft renal transplantation. Transplant Proc 26(1):292
Karam G, Maillet F, Braud G, Battisti S, Hétet JF, Glémain P, Le Normand L, Bouchot O, Rigaud J (2007) Complications chirurgicales de la transplantation rénale [Surgical complications in kidney transplantation]. Ann Urol 41(6):261–275
Prát V, Horcicková M, Matousovic K, Hatala M, Liska M (1985) Urinary tract infection in renal transplant patients. Infection 13:20710
Austin JC, Cooper CS (2004) Vesicoureteral reflux: surgical approaches. Urol Clin North Am 31(3):543–557
Krishnan A, Swana H, Mathias R, Baskin LS (2006) Redo ureteroneocystostomy using an extravesical approach in pediatric renal transplant patients with reflux: a retrospective analysis and description of technique. J Urol 176(41):1582–1587
Romero NP, Romo MIG, Vegas AG et al (2010) Deflux injections for vesicoureteral reflux in transplanted kidneys. Transplant Proc 42:2892e5
Gomez Lujan M, Velarde L, Cruzalegui C, Berrios C, Sifuentes E, Gálvez J et al (2018) Endoscopic treatment for vesicoureteral reflux in recurrent urinary tract infections in kidney transplant: experience of one center. Transplant Proc 50:5135
Akiki A, Boissier R, Delaporte V, Maurin C, Gaillet S, Karsenty G et al (2015) Endoscopic treatment of symptomatic vesicoureteral reflux after renal transplantation. J Urol 193:225e9
Frankiewicz M, Gawlik-Jakubczak T, Kostro J, Matuszewski M (2020) Minimally invasive treatment of vesico-ureteral reflux using endoscopic injection of polyacrylate-polyalcohol copolymer (Vantris) in patients after kidney transplantation. Transplant Proc 52(8):2436–2439
Balaban M, Ozkaptan O, Cubuk A, Sahan A, Duzenli M, Tuncer M (2020) Endoscopic treatment of symptomatic VUR disease after the renal transplantation: analysis of 49 cases. Clin Exp Nephrol 24(5):483–488
Cambareri G, Carpenter C, Stock J, Lewis J, Marietti S (2017) Endoscopic antireflux surgery leading to obstruction in pediatric renal transplant patients. Pediatr Transplant. https://doi.org/10.1111/petr.12838
Yucel S, Akin Y, Celik O, Erdogru T, Baykara M (2010) Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter? J Endourol 24(10):1661–1664
Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ (2012) Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol 8(4):359–365
Yap TL, Chen Y, Nah SA, Ong CC, Jacobsen A, Low Y (2016) STING versus HIT technique of endoscopic treatment for vesicoureteral reflux: a systematic review and meta-analysis. J Pediatr Surg 51(12):2015–2020
Nakamura S, Tanabe K, Hyuga T, Kubo T, Inoguchi S, Kawai S, Nakai H (2020) Mid-term safety and efficacy of the modified double hydrodistention implantation technique (HIT), termed systematic multi-site HIT (SMHIT), for patients with primary vesicoureteral reflux. Res Rep Urol 28(12):517–525
Özkaptan O, Balaban M, Çubuk A (2020) The efficiency and safety of endoscopic treatment on kidney-transplanted patients with symptomatic vesicoureteral reflux in native and transplanted renal units. Transplant Proc 52(10):3204–3208
Stenberg A, Läckgren G (1995) A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 154(2 Pt 2):800–803
Pichler R, Buttazzoni A, Rehder P, Bartsch G, Steiner H, Oswald J (2011) Endoscopic application of dextranomer/hyaluronic acid copolymer in the treatment of vesico-ureteric reflux after renal transplantation. BJU Int 107(12):1967–1972
Wang HH, Ding WF, Chu SH, Chiang YJ, Liu KL, Lin KJ, Lin CT, Wang TM (2019) Endoscopic treatment for post-transplant vesicoureteral reflux. Transplant Proc 51(5):1420–1423
Warchol S, Krzemien G, Szmigielska A, Bombinski P, Brzewski M, Dudek-Warchol T (2016) Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris). J Pediatr Urol 12(4):256.e1–4
Sharifiaghdas F, Tajalli F, Otukesh H, Shamsabadi RH (2014) Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up. J Pediatr Urol 10(6):1032–1036
Taşkinlar H, Avlan D, Bahadir GB, Delibaş A, Nayci A (2016) The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux. Int Braz J Urol 42(3):514–520
Chertin B, Arafeh WA, Zeldin A, Ostrovsky IA, Kocherov S (2013) Endoscopic correction of VUR using vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up. Urology 82(1):201–204
García-Aparicio L, Blázquez-Gómez E, Martin O, Pérez-Bertólez S, Arboleda J, Soria A, Tarrado X (2018) Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR). World J Urol 36(10):1651–1656
Funding
All authors declare no any funding for this study.
Author information
Authors and Affiliations
Contributions
Research conception and design: NCC, OO. Data acquisition: NCC,OO,BN. Statistical analysis: AO, AK. Data analysis and interpretation: NCC, OO, BN. Drafting of the manuscript: NCC, CTG. Critical revision of the manuscript: AK, CTG, BN. Administrative, technical, or material support: AO, CTG. Supervision: OO, BN. Approval of the final manuscript: NCC, AO.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no any conflict of interests.
Ethical approval
Approved by institutional ethics commitee.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Çilesiz, N.C., Onuk, Ö., Özkan, A. et al. Endoscopic treatment of vesicoureteral reflux after kidney transplantation: outcomes and predictive factors of clinical and radiological success. Int Urol Nephrol 54, 1023–1029 (2022). https://doi.org/10.1007/s11255-022-03152-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03152-1